PANCREATIC ISLET GLP-1 SECRETION IS INCREASED IN NON-DIABETIC OBESITY AND GLP-1 DIRECTLY REGULATES BETA-CELL CHOLECYSTOKININ PRODUCTION

被引：0
|
作者：
Linnemann, A. K. [1 ]
Battiola, T. J. [1 ]
Kimple, M. E. [1 ]
Davis, D. B. [1 ,3 ]
Neuman, J. C. [2 ]
Davis, D. B. [1 ,3 ]
机构：
[1] Univ Wisconsin, Med Endocrinol, Madison, WI USA
[2] Univ Wisconsin, Nutr Sci, Madison, WI USA
[3] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2015年 / 63卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
收藏
页码：667 / 667
页数：1
相关论文
共 50 条
  • [1] GLP-1 inhibits pancreatic islet cell apoptosis
    Perfetti, R
    Farilla, L
    Harlan, DH
    Hirshberg, B
    CELL TRANSPLANTATION, 2003, 12 (02) : 168 - 169
  • [2] GLP-1 inhibition of pancreatic islet cell apoptosis
    Urusova, IA
    Farilla, L
    Hui, HX
    D'Amico, E
    Perfetti, R
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (01): : 27 - 33
  • [3] GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
    Nikhil R. Gandasi
    Rui Gao
    Lakshmi Kothegala
    Abigail Pearce
    Cristiano Santos
    Samuel Acreman
    Davide Basco
    Anna Benrick
    Margarita V. Chibalina
    Anne Clark
    Claudia Guida
    Matthew Harris
    Paul R. V. Johnson
    Jakob G. Knudsen
    Jinfang Ma
    Caroline Miranda
    Makoto Shigeto
    Andrei I. Tarasov
    Ho Yan Yeung
    Bernard Thorens
    Ingrid W. Asterholm
    Quan Zhang
    Reshma Ramracheya
    Graham Ladds
    Patrik Rorsman
    Diabetologia, 2024, 67 : 528 - 546
  • [4] Beta-cell imaging with radiolabelled GLP-1 analogs
    Behe, M.
    Baumeister, P.
    Laverman, P.
    Boerman, O. C.
    Oyen, W. J. G.
    Ramaswamy, A.
    Gotthardt, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S201 - S201
  • [5] Is there evidence of beta-cell proliferation in humans with GLP-1?
    Meier, J. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 : 25 - 25
  • [6] Secretion and effects of GLP-1 on pancreatic alpha cell
    Bornez, V. Sancho
    Lupi, R.
    Faro, G.
    Lucchesi, D.
    Del Guerra, S.
    Dardano, A.
    Del Prato, S.
    DIABETOLOGIA, 2013, 56 : S236 - S236
  • [7] COST-EFFECTIVENESS OF GLP-1 MEDICATIONS IN NON-DIABETIC OBESITY POPULATION
    Lin, L. Y.
    Ghodke, O.
    Yang, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S105 - S106
  • [8] GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
    Gandasi, Nikhil R.
    Gao, Rui
    Kothegala, Lakshmi
    Pearce, Abigail
    Santos, Cristiano
    Acreman, Samuel
    Basco, Davide
    Benrick, Anna
    Chibalina, Margarita V.
    Clark, Anne
    Guida, Claudia
    Harris, Matthew
    Johnson, Paul R. V.
    Knudsen, Jakob G.
    Ma, Jinfang
    Miranda, Caroline
    Shigeto, Makoto
    Tarasov, Andrei I.
    Yeung, Ho Yan
    Thorens, Bernard
    Asterholm, Ingrid W.
    Zhang, Quan
    Ramracheya, Reshma
    Ladds, Graham
    Rorsman, Patrik
    DIABETOLOGIA, 2024, 67 (03) : 528 - 546
  • [9] AMYLIN ALTERS BIOLOGICAL EFFECTS OF GLP-1 IN THE BETA-CELL
    GOKE, R
    MCGREGOR, GP
    GOKE, B
    DIGESTION, 1993, 54 (06) : 355 - 356
  • [10] Attenuated GLP-1 secretion in obesity: Cause or consequence?
    Ranganath, LR
    Beety, JM
    Morgan, LM
    Wright, JW
    Howland, R
    Marks, V
    GUT, 1996, 38 (06) : 916 - 919
12345